Clinical trials are continually evolving, particularly in light of increasing pressures from new technologies and other disruptors. Trends ranging from AI and mHealth to patient-centricity are challenging the industry to innovate against the backdrop of looming regulatory changes and shifting competitor landscapes resulting from M&A activity. However, are these issues truly impacting clinical trials today, or is all the buzz simply white noise?
We conducted one of the biggest surveys of its kind across clinical trial professionals from within pharma, CROs, sites, service providers, academia and patient groups across the world to look beyond the hype. The final report, based on 199 responses, reveals unique insights into how companies really view these trends and to what extent they are actually implementing them in trials today.
The report also features an introduction by Citeline exploring what some of the key takeaways mean for the industry.
To download simply log in or register for an Informa Connect account, which will give you access to all our exclusive premium content.
Have any questions or interested in sponsoring future content? Email andrew.burrows@informa.com.
Log in or Create an Informa Connect Account to Access this content
Creating an account also means you'll get special access to article updates and exclusive industry content.